Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study
about
The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know?Management of achilles tendon injury: A current concepts systematic reviewAntibiotic precautions in athletesEarly steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples.Tendon Injury and Fluoroquinolone Use: A Systematic Review.Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells.Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders.A DELPHI STUDY OF RISK FACTORS FOR ACHILLES TENDINOPATHY- OPINIONS OF WORLD TENDON EXPERTSCase-crossover study design in pharmacoepidemiology: systematic review and recommendations.Predictors of primary Achilles tendon ruptures.Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?BET 2: Do fluoroquinolones increase the incidence of tendinopathy?Toxic effects of levofloxacin on rat annulus fibrosus cells: an in-vitro study.Levofloxacin increases apoptosis of rat annulus fibrosus cells via the mechanism of upregulating MMP-2 and MMP-13.Cross-cultural adaptation and validation of Persian Achilles tendon Total Rupture Score.The study on interactions between levofloxacin and model proteins by using multi-spectroscopic and molecular docking methods.Incidence, Risk Factors, and Treatment of Achilles Tendon Rupture in Patients With End-Stage Renal Disease.Non-insertional Achilles tendinopathy.Critical review on the socio-economic impact of tendinopathy.
P2860
Q24632035-0E892D5E-4502-45C0-B97B-2BC64C95782BQ27005595-C615D98C-F85E-4030-830F-12A173A3E303Q33786181-B5B73C91-5802-4EF0-93F9-026BB2297176Q34226785-582B506B-B53C-4A85-9B5D-A2E3DE686E4BQ34359994-631EE97D-CDA5-494C-8CA3-CADFCD8623C3Q34486609-0A2C521B-47D8-410D-B88C-B41EA8FEAD24Q36412964-3DA6FAB6-2696-4924-B6B3-3E68C8699243Q37304450-B942A4AB-893D-428A-B227-AB7CEFD866F3Q38137002-2AADE043-5D0F-44FF-B976-409F9CE4CB85Q38220281-8FDCBDB9-400F-4BA2-B2B2-D01062927C80Q38590850-78AB5634-1780-493C-9643-D81C35A8B258Q38823701-88EE2D7D-51FD-4683-82DB-2F337A6603BCQ38872753-899B9D85-F93B-4BA0-9EB2-B3AFA0599E05Q43012908-0D2250BC-BE9E-4467-AD82-A0CCC8DFAF2DQ43072649-04D4447C-E170-4CBF-8CB9-C3315AD8468EQ47347440-FB1E9DDA-0CF1-4150-AABA-D9C0A186480AQ48027801-DDDBDFF6-7FBE-4121-85C0-D4C07E6E575FQ54247624-FFF73288-3C01-470A-BE8D-584D0716103CQ54260071-DE6F9389-AAA9-41B3-9F35-E3F935905CA3Q55659875-414F7F09-645E-4CC7-BC8F-28549C7FBE39
P2860
Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Use of fluroquinolone and risk ...... population-based cohort study
@ast
Use of fluroquinolone and risk ...... population-based cohort study
@en
Use of fluroquinolone and risk ...... population-based cohort study
@nl
type
label
Use of fluroquinolone and risk ...... population-based cohort study
@ast
Use of fluroquinolone and risk ...... population-based cohort study
@en
Use of fluroquinolone and risk ...... population-based cohort study
@nl
prefLabel
Use of fluroquinolone and risk ...... population-based cohort study
@ast
Use of fluroquinolone and risk ...... population-based cohort study
@en
Use of fluroquinolone and risk ...... population-based cohort study
@nl
P50
P1476
Use of fluroquinolone and risk ...... population-based cohort study
@en
P2093
Niels Obel
P2888
P304
P356
10.1007/S00228-007-0265-9
P407
P577
2007-03-03T00:00:00Z
P5875
P6179
1053523253